Narinder Pal Bhalla

CHIEF MEDICAL OFFICER · LEXEO THERAPEUTICS, INC. · CIK 0002109299

FILING MIX · LIFETIME75%/25%

BUYS

SELLS

TOTAL VALUE

$98.6K

COMPANIES

ACTIVE SINCE

Feb 2026

HOLDINGS NOW

82,194

AVG SELL PX

$4.42

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Narinder Pal Bhalla. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

LXEO · 82,194 shares · as of Jul 1, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2026

FLOW · 3 buys / 1 sellsCOVERAGE · 3 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
LXEO LEXEO THERAPEUTICS, INC.	SALE Chief Medical Officer	22,306	$4.42	$98.6K	82,194	Jul 1, 2026	Jul 1, 2026 ↗	View →
LXEO LEXEO THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	55,000	—	—	104,500	Jun 29, 2026	Jul 1, 2026 ↗	View →
LXEO LEXEO THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	297,000	—	—	297,000	Feb 13, 2026	Feb 17, 2026 ↗	View →
LXEO LEXEO THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	49,500	—	—	49,500	Feb 13, 2026	Feb 17, 2026 ↗	View →

Other insiders · LXEO

Loading peer insiders…

About this filer

CIK 0002109299

ROLE

Chief Medical Officer

PRIMARY

LXEO

COMPANIES

ACTIVE SINCE

Feb 2026

MARKETPEEL · /INSIDER/0002109299DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.